首页 > 最新文献

Northern clinics of Istanbul最新文献

英文 中文
Can HALP (Hemoglobin, albumin, lymphocyte, and platelet) score distinguish malignant and benign causes of extrahepatic cholestasis in patients with extrahepatic bile duct obstruction? HALP(血红蛋白、白蛋白、淋巴细胞和血小板)评分能否区分肝外胆管梗阻患者肝外胆汁淤积的良恶性原因?
Pub Date : 2024-11-22 eCollection Date: 2024-01-01 DOI: 10.14744/nci.2024.23169
Ibrahimhalil Dusunceli, Zeynep Gok Sargin, Umut Celik, Fatih Sargin

Objective: Cholestatic diseases are common and classified as benign or malignant based on their etiology. HALP is a unique nutritional immune marker that combines indicators of nutritional status, including hemoglobin and albumin, with immune function markers like lymphocyte and platelet counts. We investigated the HALP score's ability to differentiate between benign and malignant causes in extrahepatic cholestasis patients.

Methods: This research was designed as cross-sectional and retrospective. Between 1 January 2020-1 January 2022, patients diagnosed with extrahepatic cholestasis were included. The diagnoses were confirmed using non-invasive imaging methods, ERCP (endoscopic retrograde cholangiopancreatography), and tissue biopsy results. Based on the type of extrahepatic biliary obstruction, either benign or malignant, the patients were divided into two groups. The HALP score was calculated by multiplying the patient's albumin (g/L), hemoglobin (g/L), and lymphocyte count (/L) and dividing by the platelet count (/L).

Results: In 121 of 216 patients, extrahepatic cholestasis was caused by benign factors, mostly choledocholithiasis, while malignant causes, predominantly pancreatic head cancer, were responsible for extrahepatic cholestasis in 95 patients. The malignant cholestasis group had significantly higher bilirubin levels (p<0.001), lower hemoglobin levels (p=0.005), lower albumin levels (p<0.001), higher lymphocyte counts (p<0.001), and higher platelet levels (p=0.001) compared to the benign cholestasis group. There was no considerable difference in the HALP score between the two groups, as indicated by a p-value of 0.741.

Conclusion: The HALP score could not distinguish between benign and malignant causes of extrahepatic cholestasis.

目的:胆汁淤积性疾病是一种常见的疾病,根据其病因分为良性和恶性。HALP是一种独特的营养免疫标志物,它结合了包括血红蛋白和白蛋白在内的营养状况指标,以及淋巴细胞和血小板计数等免疫功能标志物。我们研究了HALP评分在肝外胆汁淤积症患者中区分良恶性原因的能力。方法:采用横断面、回顾性研究方法。在2020年1月1日至2022年1月1日期间,被诊断为肝外胆汁淤积的患者被纳入研究。通过无创成像方法、内窥镜逆行胰胆管造影(ERCP)和组织活检结果确诊。根据肝外胆道梗阻的类型分为良性和恶性两组。HALP评分的计算方法是将患者的白蛋白(g/L)、血红蛋白(g/L)和淋巴细胞计数(/L)相乘,除以血小板计数(/L)。结果:216例肝外胆汁淤积121例为良性因素,以胆总管结石为主;95例为恶性因素,以胰头癌为主。结论:HALP评分不能区分肝外胆汁淤积的良恶性原因。
{"title":"Can HALP (Hemoglobin, albumin, lymphocyte, and platelet) score distinguish malignant and benign causes of extrahepatic cholestasis in patients with extrahepatic bile duct obstruction?","authors":"Ibrahimhalil Dusunceli, Zeynep Gok Sargin, Umut Celik, Fatih Sargin","doi":"10.14744/nci.2024.23169","DOIUrl":"10.14744/nci.2024.23169","url":null,"abstract":"<p><strong>Objective: </strong>Cholestatic diseases are common and classified as benign or malignant based on their etiology. HALP is a unique nutritional immune marker that combines indicators of nutritional status, including hemoglobin and albumin, with immune function markers like lymphocyte and platelet counts. We investigated the HALP score's ability to differentiate between benign and malignant causes in extrahepatic cholestasis patients.</p><p><strong>Methods: </strong>This research was designed as cross-sectional and retrospective. Between 1 January 2020-1 January 2022, patients diagnosed with extrahepatic cholestasis were included. The diagnoses were confirmed using non-invasive imaging methods, ERCP (endoscopic retrograde cholangiopancreatography), and tissue biopsy results. Based on the type of extrahepatic biliary obstruction, either benign or malignant, the patients were divided into two groups. The HALP score was calculated by multiplying the patient's albumin (g/L), hemoglobin (g/L), and lymphocyte count (/L) and dividing by the platelet count (/L).</p><p><strong>Results: </strong>In 121 of 216 patients, extrahepatic cholestasis was caused by benign factors, mostly choledocholithiasis, while malignant causes, predominantly pancreatic head cancer, were responsible for extrahepatic cholestasis in 95 patients. The malignant cholestasis group had significantly higher bilirubin levels (p<0.001), lower hemoglobin levels (p=0.005), lower albumin levels (p<0.001), higher lymphocyte counts (p<0.001), and higher platelet levels (p=0.001) compared to the benign cholestasis group. There was no considerable difference in the HALP score between the two groups, as indicated by a p-value of 0.741.</p><p><strong>Conclusion: </strong>The HALP score could not distinguish between benign and malignant causes of extrahepatic cholestasis.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"11 6","pages":"555-559"},"PeriodicalIF":0.0,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11622744/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142803789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systematic review of survey/questionnaire-based drug utilization studies in Turkiye. 土耳其基于调查/问卷的药物利用研究的系统回顾。
Pub Date : 2024-11-22 eCollection Date: 2024-01-01 DOI: 10.14744/nci.2024.60252
Onur Gultekin, Nazim Haspolat, Bahar Cicek, Dieudonné Havyarimana, Ahmet Akici, Volkan Aydin

Objective: Drug utilization studies (DUS), providing insights into various aspects of pharmacoepidemiology from prescribing to medication use, can be conducted through real-world data from health records and survey-based data. In this study, we aimed to describe survey/questionnaire-based DUS conducted in Turkiye.

Methods: We searched online databases for the most frequently used keywords in DUS from January 1993 till May 2023 and identified 180 survey-based DUS conducted in Turkiye. We described DUS by their populations, sociodemographic characteristics, timeframe, setting and provinces, data collection method, medication categories, and article-specific variables were evaluated.

Results: We identified that 68.3% of the DUS were in English and 91.7% were indexed in Web of Science (median 1 [interquartile range: 1-2] citation). We found that 21.7% of the articles (n=39) had pharmacology affiliation. Adults are the target population in 37.8% of the studies and age and gender were not reported in 27.2% and 16.7%, respectively. The response rate was not stated in 55.0%. We determined that 48.3% of the studies were focused on a single medication/medication group. The mean time from data collection to publication was 2.5±1.9 years, and the highest number of articles (10.6%) were published in 2021.

Conclusion: Our systematic review shows that the majority of DUS were listed in well-known international indices, suggesting that our local studies invoke global interest and hold a valuable position in health research. Nevertheless, lack of reporting of methodological characteristics in substantial part of the studies can be considered an important room for improvement of DUS.

目的:药物利用研究(DUS)可以通过来自健康记录和基于调查的数据的真实数据进行,为从处方到药物使用的药物流行病学的各个方面提供见解。在本研究中,我们旨在描述在土耳其进行的基于调查/问卷的DUS。方法:检索1993年1月至2023年5月期间在线数据库中DUS使用频率最高的关键词,并对在土耳其进行的180例基于调查的DUS进行检索。我们对DUS的人群、社会人口统计学特征、时间框架、环境和省份、数据收集方法、药物类别和文章特定变量进行了评估。结果:我们发现68.3%的DUS为英文,91.7%的DUS被Web of Science收录(中位数为1[四分位数间距:1-2])。我们发现21.7%的文章(n=39)有药理学关联。37.8%的研究以成年人为目标人群,27.2%和16.7%的研究分别未报告年龄和性别。55.0%的回复率未注明。我们确定48.3%的研究集中于单一药物/药物组。从数据收集到发表的平均时间为2.5±1.9年,发表的文章数最多(10.6%)发生在2021年。结论:我们的系统综述显示,大多数DUS被列入国际知名指标,表明我们的本地研究引起了全球的关注,在卫生研究中具有重要的地位。然而,在大部分研究中缺乏方法特征的报告可以被认为是DUS改进的一个重要空间。
{"title":"Systematic review of survey/questionnaire-based drug utilization studies in Turkiye.","authors":"Onur Gultekin, Nazim Haspolat, Bahar Cicek, Dieudonné Havyarimana, Ahmet Akici, Volkan Aydin","doi":"10.14744/nci.2024.60252","DOIUrl":"10.14744/nci.2024.60252","url":null,"abstract":"<p><strong>Objective: </strong>Drug utilization studies (DUS), providing insights into various aspects of pharmacoepidemiology from prescribing to medication use, can be conducted through real-world data from health records and survey-based data. In this study, we aimed to describe survey/questionnaire-based DUS conducted in Turkiye.</p><p><strong>Methods: </strong>We searched online databases for the most frequently used keywords in DUS from January 1993 till May 2023 and identified 180 survey-based DUS conducted in Turkiye. We described DUS by their populations, sociodemographic characteristics, timeframe, setting and provinces, data collection method, medication categories, and article-specific variables were evaluated.</p><p><strong>Results: </strong>We identified that 68.3% of the DUS were in English and 91.7% were indexed in Web of Science (median 1 [interquartile range: 1-2] citation). We found that 21.7% of the articles (n=39) had pharmacology affiliation. Adults are the target population in 37.8% of the studies and age and gender were not reported in 27.2% and 16.7%, respectively. The response rate was not stated in 55.0%. We determined that 48.3% of the studies were focused on a single medication/medication group. The mean time from data collection to publication was 2.5±1.9 years, and the highest number of articles (10.6%) were published in 2021.</p><p><strong>Conclusion: </strong>Our systematic review shows that the majority of DUS were listed in well-known international indices, suggesting that our local studies invoke global interest and hold a valuable position in health research. Nevertheless, lack of reporting of methodological characteristics in substantial part of the studies can be considered an important room for improvement of DUS.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"11 6","pages":"525-533"},"PeriodicalIF":0.0,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11622752/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142804100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vena cava and renal vein thrombosis with pheochromocytoma: A case report. 嗜铬细胞瘤并发腔静脉及肾静脉血栓1例。
Pub Date : 2024-11-22 eCollection Date: 2024-01-01 DOI: 10.14744/nci.2023.58997
Ramazan Gundogdu, Kenan Caliskan, Ufuk Uylas, Nazim Emrah Kocer

Pheochromocytomas are potentially malignant and may manifest with vascular thrombi. We present the treatment of a patient with pheochromocytoma and tumor thrombosis of the renal vein and inferior vena cava. A thirty-eight-year-old male patient was admitted complaining of abdominal pain and headache. High levels of urinary catecholamine were detected. Magnetic resonance imaging revealed left pheochromocytoma with thrombosis of the inferior vena cava and the left renal vein. A left adrenalectomy and a thrombectomy with cavotomy were performed. The pathology results reported a 9.5 cm malignant pheochromocytoma. The patient's symptoms dissipated after the operation and there were no signs of recurrence at the two-month follow-up. Preoperative radiological diagnostic examinations are valuable in the planning of pheochromocytoma surgery. We believe that adrenalectomy and thrombectomy can be performed on pheochromocytoma patients with vascular thrombi with low morbidity.

嗜铬细胞瘤是潜在的恶性肿瘤,可能表现为血管血栓。我们报告一例嗜铬细胞瘤合并肾静脉及下腔静脉肿瘤血栓的治疗。一名三十八岁男性病人入院,主诉腹痛及头痛。尿中儿茶酚胺含量高。磁共振显示左侧嗜铬细胞瘤伴下腔静脉及左肾静脉血栓形成。行左肾上腺切除术和血栓切除伴腔腔切除术。病理结果为9.5 cm恶性嗜铬细胞瘤。术后患者症状消失,随访2个月无复发迹象。术前放射诊断检查对嗜铬细胞瘤手术的规划是有价值的。我们认为肾上腺切除术和血栓切除术可用于低发病率的嗜铬细胞瘤血管血栓患者。
{"title":"Vena cava and renal vein thrombosis with pheochromocytoma: A case report.","authors":"Ramazan Gundogdu, Kenan Caliskan, Ufuk Uylas, Nazim Emrah Kocer","doi":"10.14744/nci.2023.58997","DOIUrl":"10.14744/nci.2023.58997","url":null,"abstract":"<p><p>Pheochromocytomas are potentially malignant and may manifest with vascular thrombi. We present the treatment of a patient with pheochromocytoma and tumor thrombosis of the renal vein and inferior vena cava. A thirty-eight-year-old male patient was admitted complaining of abdominal pain and headache. High levels of urinary catecholamine were detected. Magnetic resonance imaging revealed left pheochromocytoma with thrombosis of the inferior vena cava and the left renal vein. A left adrenalectomy and a thrombectomy with cavotomy were performed. The pathology results reported a 9.5 cm malignant pheochromocytoma. The patient's symptoms dissipated after the operation and there were no signs of recurrence at the two-month follow-up. Preoperative radiological diagnostic examinations are valuable in the planning of pheochromocytoma surgery. We believe that adrenalectomy and thrombectomy can be performed on pheochromocytoma patients with vascular thrombi with low morbidity.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"11 6","pages":"583-585"},"PeriodicalIF":0.0,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11622754/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142804217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Do we know about dynapenia? 我们知道动力缺失吗?
Pub Date : 2024-11-22 eCollection Date: 2024-01-01 DOI: 10.14744/nci.2024.48642
Ridvan Sivritepe, Ozge Kiran Siyer, Serhat Mert Tiril, Sema Ucak Basat

Dynapenia is a condition characterized by decreased muscle strength and function in older adults that is not due to a specific underlying disease or medical condition. Dynapenia is common among older adults and has significant health effects, including functional impairment, disability, increased risk of falls, hospitalization, and death. Oxidative stress, mitochondrial dysfunction and chronic inflammation are involved in the etiopathophysiology of dynapenia. Diagnosis of dynapenia is based on the evaluation of muscle strength and function using methods such as hand grip strength, timed up and go test and short physical performance battery. Management of dynapenia involves a multifaceted approach that includes exercise, nutrition, pharmacological interventions, management of underlying medical conditions, and fall prevention strategies. With appropriate interventions, older adults with dynapenia can improve muscle strength and function, reduce the risk of falls and disability, and maintain their independence and quality of life.

动力不足是一种以老年人肌肉力量和功能下降为特征的疾病,不是由于特定的潜在疾病或医学状况。动力不足在老年人中很常见,对健康有重大影响,包括功能损害、残疾、跌倒、住院和死亡的风险增加。氧化应激、线粒体功能障碍和慢性炎症参与了运动障碍的发病生理机制。动力不足的诊断是基于对肌肉力量和功能的评估,使用的方法包括手握力、定时起跑测试和短时间物理性能电池。运动障碍的管理涉及多方面的方法,包括运动、营养、药物干预、潜在医疗条件的管理和预防跌倒的策略。通过适当的干预,患有运动障碍的老年人可以改善肌肉力量和功能,降低跌倒和残疾的风险,并保持其独立性和生活质量。
{"title":"Do we know about dynapenia?","authors":"Ridvan Sivritepe, Ozge Kiran Siyer, Serhat Mert Tiril, Sema Ucak Basat","doi":"10.14744/nci.2024.48642","DOIUrl":"10.14744/nci.2024.48642","url":null,"abstract":"<p><p>Dynapenia is a condition characterized by decreased muscle strength and function in older adults that is not due to a specific underlying disease or medical condition. Dynapenia is common among older adults and has significant health effects, including functional impairment, disability, increased risk of falls, hospitalization, and death. Oxidative stress, mitochondrial dysfunction and chronic inflammation are involved in the etiopathophysiology of dynapenia. Diagnosis of dynapenia is based on the evaluation of muscle strength and function using methods such as hand grip strength, timed up and go test and short physical performance battery. Management of dynapenia involves a multifaceted approach that includes exercise, nutrition, pharmacological interventions, management of underlying medical conditions, and fall prevention strategies. With appropriate interventions, older adults with dynapenia can improve muscle strength and function, reduce the risk of falls and disability, and maintain their independence and quality of life.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"11 6","pages":"593-599"},"PeriodicalIF":0.0,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11622748/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142804052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of the presence of Epstein-Barr virus in patients who had Oral Lichen Planus and Oral Lichenoid Contact Lesions with Real-time PCR method in serum, tissue, and saliva samples. 实时荧光定量PCR法检测口腔扁平苔藓和口腔类地衣接触病变患者血清、组织和唾液中eb病毒的存在
Pub Date : 2024-11-22 eCollection Date: 2024-01-01 DOI: 10.14744/nci.2024.63239
Alaeddin Oral, Mustafa Onel, Mehmet Demirci, Cem Baysal, Arat Hulikyan, Hayriye Kirkoyun Uysal, Ali Agacfidan, Sertan Ergun

Objective: Oral Lichen Planus (OLP) is an immune system disease and its cause has not been fully determined yet. Oral Lichenoid Contact Lesions (OLCL) is an allergic condition known to develop because of dental materials. It is considered that some infectious agents (e.g., Epstein-Barr virus (EBV)) play roles in the etiology of OLP and OLCL. The purpose of the present study was to investigate the presence of EBV in different clinical samples of patients who had OLP and OLCL, to show its relationship with OLCL, and to determine its role in etiopathogenesis in these patients.

Methods: Twenty (20) OLCL, twenty-three (23) OLP, and twenty (20) healthy volunteers who applied to Istanbul University Faculty of Dentistry, Oral and Maxillofacial Surgery were included in the study, regardless of gender. Biopsy samples were taken from patients who had a 5mm punch, including the mucosa containing the lesion along with saliva and blood samples, and all clinical samples were sent to the Department of Medical Microbiology Laboratory under appropriate storage conditions. After the isolation of the DNA from clinical samples, EBV DNA was analyzed on the Light Cycler 480 II device by using Real-time PCR (RT-PCR) tests. The evaluation of the statistical data of the results was made by using the SPSS program.

Results: When the data were evaluated, EBV DNA positivity was detected in 13.04% of the patients who had OLP, 10% of the patients who had OLCL, and 5% of the individuals in the Control Group. In saliva samples, EBV DNA was found positive in 21.74% of individuals with OLP, 15% of individuals with OLCL, and 10% of individuals in the Control Group. In the biopsy samples, EBV DNA was detected positive in 21.74% of the OLP patients, 15% of the OLCL patients, and 10% of the Control Group individuals.

Conclusion: Based on the findings of the present study, no significant differences were observed in the presence of EBV DNA or the quantitative viral load between patients with OLP, OLCL, and the Control Group. However, the quantitative EBV DNA results varied depending on the type of clinical sample selected. We believe that comprehensive studies that will include a larger number of samples must be conducted to determine the role of EBV in OLP and OLCL.

目的:口腔扁平苔藓(OLP)是一种免疫系统疾病,其病因尚未完全确定。口腔地衣样物质接触性病变(OLCL)是一种已知的由牙齿材料引起的过敏性疾病。一些感染因子(如eb病毒)被认为在OLP和OLCL的病因中起作用。本研究的目的是调查EBV在OLP和OLCL患者的不同临床样本中的存在,显示其与OLCL的关系,并确定其在这些患者的发病机制中的作用。方法:20名OLCL、23名OLP和20名健康志愿者申请伊斯坦布尔大学牙科、口腔颌面外科学院,不分性别。对5mm穿孔患者取活检标本,包括病变粘膜、唾液和血液标本,所有临床标本送医学微生物科实验室,保存条件适宜。从临床样品中分离出EBV DNA后,在Light Cycler 480 II装置上采用实时荧光定量PCR (RT-PCR)检测。采用SPSS软件对结果的统计数据进行评价。结果:在评估数据时,13.04%的OLP患者、10%的OLCL患者和5%的对照组中检测到EBV DNA阳性。在唾液样本中,21.74%的OLP患者、15%的OLCL患者和10%的对照组患者的EBV DNA呈阳性。在活检样本中,21.74%的OLP患者、15%的OLCL患者和10%的对照组个体检测到EBV DNA阳性。结论:根据本研究的结果,在OLP、OLCL患者和对照组之间,EBV DNA的存在或定量病毒载量没有显著差异。然而,EBV DNA的定量结果因所选临床样本的类型而异。我们认为,必须进行包括更多样本的全面研究,以确定EBV在OLP和OLCL中的作用。
{"title":"Investigation of the presence of Epstein-Barr virus in patients who had Oral Lichen Planus and Oral Lichenoid Contact Lesions with Real-time PCR method in serum, tissue, and saliva samples.","authors":"Alaeddin Oral, Mustafa Onel, Mehmet Demirci, Cem Baysal, Arat Hulikyan, Hayriye Kirkoyun Uysal, Ali Agacfidan, Sertan Ergun","doi":"10.14744/nci.2024.63239","DOIUrl":"10.14744/nci.2024.63239","url":null,"abstract":"<p><strong>Objective: </strong>Oral Lichen Planus (OLP) is an immune system disease and its cause has not been fully determined yet. Oral Lichenoid Contact Lesions (OLCL) is an allergic condition known to develop because of dental materials. It is considered that some infectious agents (e.g., Epstein-Barr virus (EBV)) play roles in the etiology of OLP and OLCL. The purpose of the present study was to investigate the presence of EBV in different clinical samples of patients who had OLP and OLCL, to show its relationship with OLCL, and to determine its role in etiopathogenesis in these patients.</p><p><strong>Methods: </strong>Twenty (20) OLCL, twenty-three (23) OLP, and twenty (20) healthy volunteers who applied to Istanbul University Faculty of Dentistry, Oral and Maxillofacial Surgery were included in the study, regardless of gender. Biopsy samples were taken from patients who had a 5mm punch, including the mucosa containing the lesion along with saliva and blood samples, and all clinical samples were sent to the Department of Medical Microbiology Laboratory under appropriate storage conditions. After the isolation of the DNA from clinical samples, EBV DNA was analyzed on the Light Cycler 480 II device by using Real-time PCR (RT-PCR) tests. The evaluation of the statistical data of the results was made by using the SPSS program.</p><p><strong>Results: </strong>When the data were evaluated, EBV DNA positivity was detected in 13.04% of the patients who had OLP, 10% of the patients who had OLCL, and 5% of the individuals in the Control Group. In saliva samples, EBV DNA was found positive in 21.74% of individuals with OLP, 15% of individuals with OLCL, and 10% of individuals in the Control Group. In the biopsy samples, EBV DNA was detected positive in 21.74% of the OLP patients, 15% of the OLCL patients, and 10% of the Control Group individuals.</p><p><strong>Conclusion: </strong>Based on the findings of the present study, no significant differences were observed in the presence of EBV DNA or the quantitative viral load between patients with OLP, OLCL, and the Control Group. However, the quantitative EBV DNA results varied depending on the type of clinical sample selected. We believe that comprehensive studies that will include a larger number of samples must be conducted to determine the role of EBV in OLP and OLCL.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"11 6","pages":"569-574"},"PeriodicalIF":0.0,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11622749/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142804156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient satisfaction with health care services in Turkiye: A glimpse from nationwide Ministry of Health database. 土耳其患者对医疗保健服务的满意度:来自全国卫生部数据库的一瞥。
Pub Date : 2024-11-21 eCollection Date: 2024-01-01 DOI: 10.14744/nci.2024.84584
Suayip Birinci, Serdar Can Guven, Naim Ata, Mustafa Mahir Ulgu, Orhan Kucuksahin

Objective: Patient satisfaction refers to the degree to which patients' expectations from health care services are met and is a critical indicator used to measure the overall quality of this service. This study aims to analyze overall patient satisfaction and regarding factors in our country, providing valuable insights for policymakers, clinicians, and researchers who aim to improve the quality of health care services and patient outcomes. Furthermore, as a nationwide assessment, this study reveals the potential of big data analytics in health services.

Methods: Integrated e-Pulse and Health Statistics and Causal Analysis (SINA) systems were used to gather satisfaction scores given by patients after any health care service obtained for overall health care service, physician, personnel other than physician, sanitization (from 0 to 100). The data were processed and analyzed using libraries Pandas and NumPy in the Python programming language.

Results: A total of 37.674.978 scores were given by a total of 11.421.857 patients regarding health care service they obtained involving ratings of 207.339 physicians, between the years of 2016 and 2023. Mean health care rating was 80.4 over 100, mean physician rating was 82, mean rating for personnel other than physicians was 78.4 and mean rating for sanitization was 77.7. When the top 15 most scored facilities were investigated, overall point was highest for Family Medicine centers (94.62) and lowest for Women's Health and Pediatric Diseases hospitals. When rate of 100 points given for each clinic after an admission was investigated, it was lowest for emergency medicine, pediatric emergency medicine, dentistry, endodontia, dermatology and pandemic clinics, and highest for oncology, radiation oncology and family medicine clinics. Waiting time to admission and length of hospital stay seemed to be important factors for patient satisfaction.

Conclusion: This is the largest study regarding patient satisfaction in Turkiye and was conducted by the foremost health care provider, the Ministry of Health. This limited data may provide implications to be assessed to keep the positive trend in our country in patient satisfaction and future analyses evaluating infinite potential factors to hasten the progress of health care in our country.

目的:患者满意度是指患者对医疗服务的期望得到满足的程度,是衡量医疗服务整体质量的重要指标。本研究旨在分析我国整体患者满意度及其相关因素,为决策者、临床医生和研究人员提供有价值的见解,以提高医疗服务质量和患者预后。此外,作为一项全国性的评估,这项研究揭示了大数据分析在卫生服务中的潜力。方法:采用综合e-Pulse和健康统计与原因分析(SINA)系统,收集患者在接受任何医疗服务后对总体医疗服务、医师、非医师人员、卫生处理的满意度评分(0 ~ 100分)。使用Python编程语言中的Pandas和NumPy库对数据进行处理和分析。结果:2016年至2023年,共有11.421.857名患者对其获得的医疗服务评分37.674.978分,涉及207.339名医生评分。卫生保健平均评分为80.4分(满分100分),医师平均评分为82分,非医师人员平均评分为78.4分,卫生处理平均评分为77.7分。在对得分最高的15家医院进行调查时,家庭医学中心的综合得分最高(94.62分),妇女保健和儿科疾病医院的综合得分最低。在对每个门诊进行100分调查时,急诊、小儿急诊、牙科、牙髓、皮肤科、流行病门诊的得分最低,而肿瘤科、放射肿瘤科、家庭医学门诊的得分最高。住院等待时间和住院时间似乎是影响患者满意度的重要因素。结论:这是土耳其最大的关于患者满意度的研究,由最重要的卫生保健提供者卫生部进行。这些有限的数据可能会提供一些值得评估的影响,以保持我国患者满意度的积极趋势,并在未来的分析中评估无限的潜在因素,以加速我国医疗保健的进步。
{"title":"Patient satisfaction with health care services in Turkiye: A glimpse from nationwide Ministry of Health database.","authors":"Suayip Birinci, Serdar Can Guven, Naim Ata, Mustafa Mahir Ulgu, Orhan Kucuksahin","doi":"10.14744/nci.2024.84584","DOIUrl":"10.14744/nci.2024.84584","url":null,"abstract":"<p><strong>Objective: </strong>Patient satisfaction refers to the degree to which patients' expectations from health care services are met and is a critical indicator used to measure the overall quality of this service. This study aims to analyze overall patient satisfaction and regarding factors in our country, providing valuable insights for policymakers, clinicians, and researchers who aim to improve the quality of health care services and patient outcomes. Furthermore, as a nationwide assessment, this study reveals the potential of big data analytics in health services.</p><p><strong>Methods: </strong>Integrated e-Pulse and Health Statistics and Causal Analysis (SINA) systems were used to gather satisfaction scores given by patients after any health care service obtained for overall health care service, physician, personnel other than physician, sanitization (from 0 to 100). The data were processed and analyzed using libraries Pandas and NumPy in the Python programming language.</p><p><strong>Results: </strong>A total of 37.674.978 scores were given by a total of 11.421.857 patients regarding health care service they obtained involving ratings of 207.339 physicians, between the years of 2016 and 2023. Mean health care rating was 80.4 over 100, mean physician rating was 82, mean rating for personnel other than physicians was 78.4 and mean rating for sanitization was 77.7. When the top 15 most scored facilities were investigated, overall point was highest for Family Medicine centers (94.62) and lowest for Women's Health and Pediatric Diseases hospitals. When rate of 100 points given for each clinic after an admission was investigated, it was lowest for emergency medicine, pediatric emergency medicine, dentistry, endodontia, dermatology and pandemic clinics, and highest for oncology, radiation oncology and family medicine clinics. Waiting time to admission and length of hospital stay seemed to be important factors for patient satisfaction.</p><p><strong>Conclusion: </strong>This is the largest study regarding patient satisfaction in Turkiye and was conducted by the foremost health care provider, the Ministry of Health. This limited data may provide implications to be assessed to keep the positive trend in our country in patient satisfaction and future analyses evaluating infinite potential factors to hasten the progress of health care in our country.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"11 6","pages":"495-500"},"PeriodicalIF":0.0,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11622745/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142804165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The frequency of macroprolactinemia among patients with hyperprolactinemia in a central laboratory of a training and research hospital. 某培训研究型医院中心实验室高催乳素血症患者中巨催乳素血症的发生频率
Pub Date : 2024-11-21 eCollection Date: 2024-01-01 DOI: 10.14744/nci.2023.94758
Nilufer Bayraktar

Objective: Macroprolactinemia is a well-described endocrine disorder, with its results leading to unnecessary tests and overtreatment. However, routine macroprolactin screening is not performed in many laboratories. Routinely used prolactin assays can result in false diagnosis of hyperprolactinemia in patients with no signs and symptoms related to hyperprolactinemia and clinicians should be aware of macroprolactinemia frequency encountered with the method in use. In this study, it was aimed to examine the frequency of macroprolactinemia among patients with hyperprolactinemia.

Methods: Prolactin analyses were performed on Roche Cobas® e801 immunoanalyzer using the Elecsys Prolactin II electrochemiluminesence immunoassay (Roche Diagnostics, Mannheim, Germany). Samples were provided from 14 different hospitals in total and evaluated with the same method in a single central laboratory. In order to precipitate the samples for macroprolactin analysis, polyethylene glycol (PEG) 6000 was used.

Results: In this study, we evaluated 1100 patients with hyperprolactinemia and determined the frequency of macroprolactinemia to be 9.6% (recovery cut-off value <40%), while 8.5% of the patients were in the gray zone (recovery cut-off value 40% to <60%).

Conclusion: Laboratories should consider regularly screening for macroprolactinemia in all hyperprolactinemic samples and collaborate with clinicians to raise awareness about the prevalence of this condition.

目的:巨催乳素血症是一种描述良好的内分泌紊乱,其结果导致不必要的检查和过度治疗。然而,常规的催乳素筛查并没有在许多实验室进行。常规使用的催乳素检测可能导致没有与高催乳素血症相关体征和症状的患者误诊为高催乳素血症,临床医生应了解使用该方法时遇到的高催乳素血症频率。本研究旨在探讨高催乳素血症患者出现大催乳素血症的频率。方法:催乳素分析采用罗氏Cobas®e801免疫分析仪,使用Elecsys催乳素II电化学发光免疫分析法(罗氏诊断公司,曼海姆,德国)。样本总共来自14家不同的医院,并在一个中心实验室用相同的方法进行评估。用聚乙二醇(PEG) 6000沉淀样品进行催乳素分析。结果:本研究对1100例高泌乳素血症患者进行了评估,确定了高泌乳素血症的发生率为9.6%(恢复临界值)。结论:实验室应考虑定期筛查所有高泌乳素血症样本中的高泌乳素血症,并与临床医生合作提高对该疾病患病率的认识。
{"title":"The frequency of macroprolactinemia among patients with hyperprolactinemia in a central laboratory of a training and research hospital.","authors":"Nilufer Bayraktar","doi":"10.14744/nci.2023.94758","DOIUrl":"10.14744/nci.2023.94758","url":null,"abstract":"<p><strong>Objective: </strong>Macroprolactinemia is a well-described endocrine disorder, with its results leading to unnecessary tests and overtreatment. However, routine macroprolactin screening is not performed in many laboratories. Routinely used prolactin assays can result in false diagnosis of hyperprolactinemia in patients with no signs and symptoms related to hyperprolactinemia and clinicians should be aware of macroprolactinemia frequency encountered with the method in use. In this study, it was aimed to examine the frequency of macroprolactinemia among patients with hyperprolactinemia.</p><p><strong>Methods: </strong>Prolactin analyses were performed on Roche Cobas<sup>®</sup> e801 immunoanalyzer using the Elecsys Prolactin II electrochemiluminesence immunoassay (Roche Diagnostics, Mannheim, Germany). Samples were provided from 14 different hospitals in total and evaluated with the same method in a single central laboratory. In order to precipitate the samples for macroprolactin analysis, polyethylene glycol (PEG) 6000 was used.</p><p><strong>Results: </strong>In this study, we evaluated 1100 patients with hyperprolactinemia and determined the frequency of macroprolactinemia to be 9.6% (recovery cut-off value <40%), while 8.5% of the patients were in the gray zone (recovery cut-off value 40% to <60%).</p><p><strong>Conclusion: </strong>Laboratories should consider regularly screening for macroprolactinemia in all hyperprolactinemic samples and collaborate with clinicians to raise awareness about the prevalence of this condition.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"11 6","pages":"520-524"},"PeriodicalIF":0.0,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11622756/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142804212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changes in the frequency, presentation and surgical outcomes of complicated appendicitis during the pandemic. 大流行期间复杂性阑尾炎发生频率、表现和手术结果的变化
Pub Date : 2024-11-20 eCollection Date: 2024-01-01 DOI: 10.14744/nci.2024.58897
Tunc Eren, Leyla Zeynep Tigrel, Abdullah Kayali, Ahmet Naci Emecen, Ayse Nur Toksoz Yildirim, Hasan Huseyin Mutlu, Ozgur Ekinci, Orhan Alimoglu

Objective: Coronavirus Disease 2019 (COVID-19) has affected every aspect of human life and all health care systems globally. The aim of this study was to investigate the effect of COVID-19 pandemic on the frequency, presentation and surgical outcomes of complicated appendicitis.

Methods: Patients who underwent appendectomy for acute appendicitis one year before and one year after the declaration of the pandemic were investigated. Demographics and diagnostic findings as well as surgical and histopathological outcomes were recorded and statistically analyzed.

Results: The study group of 409 patients was composed of 241 cases in the pre-pandemic group and 168 cases in the pandemic group revealing that the weekly total number of appendectomies decreased during the pandemic [pre-pandemic, median (IQR): 5 (3-6); pandemic, median (IQR): 3 (2-5); p=0.005]. The pandemic group was significantly associated with a longer time from emergency department admission to hospitalization, increased mean blood C-reactive protein levels and increased rate of postoperative complications (p=0.024, p=0.038 and p=0.004, respectively). Most importantly, pathological examinations revealed a higher number of complicated appendicitis cases in the pandemic group when compared to the pre-pandemic group [26 (15.5%) vs. 19 (7.9%), respectively] which corresponded to a 2.1-fold higher risk of being diagnosed with complicated appendicitis during the pandemic [OR: 2.1 (95% CI: 1.1-4.1), p=0.024].

Conclusion: While fewer appendectomies were performed during the pandemic, the incidence of complicated appendicitis and postoperative complications increased considerably.

2019冠状病毒病(COVID-19)已经影响了全球人类生活的方方面面和所有卫生保健系统。本研究的目的是探讨COVID-19大流行对复杂性阑尾炎的发生率、表现和手术结果的影响。方法:对大流行宣布前1年和宣布后1年因急性阑尾炎行阑尾切除术的患者进行调查。记录人口统计学和诊断结果以及手术和组织病理学结果并进行统计分析。结果:409例患者的研究组由大流行前组的241例和大流行组的168例组成,表明大流行期间每周阑尾切除术总数减少[大流行前,中位数(IQR): 5 (3-6);大流行,中位数(IQR): 3 (2-5);p = 0.005)。大流行组与急诊科入院至住院时间较长、平均血c反应蛋白水平升高和术后并发症发生率升高显著相关(p=0.024、p=0.038和p=0.004)。最重要的是,病理检查显示,与大流行前组相比,大流行组中复杂阑尾炎病例的数量更高[分别为26例(15.5%)对19例(7.9%)],这相当于大流行期间诊断为复杂阑尾炎的风险高出2.1倍[OR: 2.1 (95% CI: 1.1-4.1), p=0.024]。结论:流感大流行期间阑尾炎手术虽少,但复杂性阑尾炎及术后并发症的发生率明显增加。
{"title":"Changes in the frequency, presentation and surgical outcomes of complicated appendicitis during the pandemic.","authors":"Tunc Eren, Leyla Zeynep Tigrel, Abdullah Kayali, Ahmet Naci Emecen, Ayse Nur Toksoz Yildirim, Hasan Huseyin Mutlu, Ozgur Ekinci, Orhan Alimoglu","doi":"10.14744/nci.2024.58897","DOIUrl":"10.14744/nci.2024.58897","url":null,"abstract":"<p><strong>Objective: </strong>Coronavirus Disease 2019 (COVID-19) has affected every aspect of human life and all health care systems globally. The aim of this study was to investigate the effect of COVID-19 pandemic on the frequency, presentation and surgical outcomes of complicated appendicitis.</p><p><strong>Methods: </strong>Patients who underwent appendectomy for acute appendicitis one year before and one year after the declaration of the pandemic were investigated. Demographics and diagnostic findings as well as surgical and histopathological outcomes were recorded and statistically analyzed.</p><p><strong>Results: </strong>The study group of 409 patients was composed of 241 cases in the pre-pandemic group and 168 cases in the pandemic group revealing that the weekly total number of appendectomies decreased during the pandemic [pre-pandemic, median (IQR): 5 (3-6); pandemic, median (IQR): 3 (2-5); p=0.005]. The pandemic group was significantly associated with a longer time from emergency department admission to hospitalization, increased mean blood C-reactive protein levels and increased rate of postoperative complications (p=0.024, p=0.038 and p=0.004, respectively). Most importantly, pathological examinations revealed a higher number of complicated appendicitis cases in the pandemic group when compared to the pre-pandemic group [26 (15.5%) vs. 19 (7.9%), respectively] which corresponded to a 2.1-fold higher risk of being diagnosed with complicated appendicitis during the pandemic [OR: 2.1 (95% CI: 1.1-4.1), p=0.024].</p><p><strong>Conclusion: </strong>While fewer appendectomies were performed during the pandemic, the incidence of complicated appendicitis and postoperative complications increased considerably.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"11 6","pages":"547-554"},"PeriodicalIF":0.0,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11622751/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142803951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in minimally invasive liver surgery. 微创肝脏手术的进展。
Pub Date : 2024-11-20 eCollection Date: 2024-01-01 DOI: 10.14744/nci.2024.42744
Hilmi Anil Dincer, Ahmet Bulent Dogrul

As in many surgical branches, minimally invasive methods are becoming increasingly prominent in hepatobiliary surgery. Nowadays, robotic and laparoscopic methods are among the hot topics in the current literature. Both laparoscopic and robotic surgery have better short-term results than open surgery in terms of the blood loss, need for blood transfusion, length of intensive care unit and hospital stay, and postoperative major complication rate. In addition to cosmetic benefits, minimally invasive methods have similar results to open surgery in terms of oncologic outcomes. Minimally invasive techniques for hepatocellular carcinoma, colorectal cancer liver metastasis and cholangiocarcinoma, which are the most common indications for surgery, also for donor and recipient surgeries in organ transplantation, can be safely applied in high-volume centers and by experienced surgeons. The use of robotic surgery is increasing especially in major hepatectomy operations. The main advantages of robotic surgery over laparoscopic surgery are less bleeding, less conversion rate and a shorter learning curve. However, there is a need for studies investigating the cost-effectiveness of robotic surgery, the production of devices such as robotic ultrasonographic dissectors, and the establishment of structured minimally invasive hepatobiliary surgery training programs. The aim of this review is to evaluate the recent findings and current evidence on minimally invasive hepatobiliary surgery.

在许多外科分支中,微创方法在肝胆外科中越来越突出。目前,机器人和腹腔镜方法是当前文献中的热门话题。腹腔镜和机器人手术在出血量、输血需要、重症监护病房和住院时间、术后主要并发症发生率等方面的短期效果都优于开放手术。除了美容方面的好处,微创方法在肿瘤预后方面与开放手术有相似的结果。肝细胞癌、结直肠癌、肝转移和胆管癌是最常见的手术适应症,微创技术可以安全地应用于器官移植的供体和受体手术,并由经验丰富的外科医生应用。机器人手术的使用越来越多,特别是在主要的肝切除手术中。与腹腔镜手术相比,机器人手术的主要优点是出血少,转换率低,学习曲线短。然而,有必要研究机器人手术的成本效益,机器人超声解剖器等设备的生产,以及结构化微创肝胆手术培训计划的建立。本综述的目的是评价微创肝胆手术的最新发现和现有证据。
{"title":"Advances in minimally invasive liver surgery.","authors":"Hilmi Anil Dincer, Ahmet Bulent Dogrul","doi":"10.14744/nci.2024.42744","DOIUrl":"10.14744/nci.2024.42744","url":null,"abstract":"<p><p>As in many surgical branches, minimally invasive methods are becoming increasingly prominent in hepatobiliary surgery. Nowadays, robotic and laparoscopic methods are among the hot topics in the current literature. Both laparoscopic and robotic surgery have better short-term results than open surgery in terms of the blood loss, need for blood transfusion, length of intensive care unit and hospital stay, and postoperative major complication rate. In addition to cosmetic benefits, minimally invasive methods have similar results to open surgery in terms of oncologic outcomes. Minimally invasive techniques for hepatocellular carcinoma, colorectal cancer liver metastasis and cholangiocarcinoma, which are the most common indications for surgery, also for donor and recipient surgeries in organ transplantation, can be safely applied in high-volume centers and by experienced surgeons. The use of robotic surgery is increasing especially in major hepatectomy operations. The main advantages of robotic surgery over laparoscopic surgery are less bleeding, less conversion rate and a shorter learning curve. However, there is a need for studies investigating the cost-effectiveness of robotic surgery, the production of devices such as robotic ultrasonographic dissectors, and the establishment of structured minimally invasive hepatobiliary surgery training programs. The aim of this review is to evaluate the recent findings and current evidence on minimally invasive hepatobiliary surgery.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"11 6","pages":"586-592"},"PeriodicalIF":0.0,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11622747/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142803662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Determination of nutritional status and protein-energy wasting in patients with diabetic nephropathy. 糖尿病肾病患者营养状况和蛋白质能量消耗的测定。
Pub Date : 2024-11-19 eCollection Date: 2024-01-01 DOI: 10.14744/nci.2023.66503
Elif Karakas, Hatice Colak, Fatma Esra Gunes, Berna Karakoyun

Objective: This study aims to evaluate the nutritional status of patients with stage 3 and 4 diabetic nephropathy (DN; DN-3 and DN-4) and to explain the effect of DN stages on the prognosis of protein-energy wasting (PEW).

Methods: Data from demographic characteristics, anthropometric measurements, biochemical findings, food consumption records, and the Subjective Global Assessment (SGA) screening tool of 49 patients (25 DN-3; 24 DN-4) who were followed at the nephrology department were collected. The criteria of the International Society of Renal Nutrition and Metabolism (ISRNM) were used to determine PEW.

Results: 56% of DN-3 and 66.7% of DN-4 have been diagnosed with diabetes for over 15 years. The groups differed in total body weight, body-muscle weight, creatinine, microalbuminuria, and eGFR values (p<0.05). Protein (g/kg) intake was only different between the groups (p<0.05). 18.4% of patients had SGA-B score, and 26.5% had PEW.

Conclusion: Our study provides a general impression about the presence of PEW in DN patients not receiving dialysis in Turkiye. In patients with DN-3 and DN-4, daily energy and macronutrient intakes are adequate by recommendation. According to ISRNM criteria, the prevalence of PEW increased with advancing disease stage. PEW was observed to be more effective than SGA in assessing malnutrition.

目的:本研究旨在评估3期和4期糖尿病肾病(DN;DN-3和DN-4),并解释DN分期对蛋白质-能量消耗(PEW)预后的影响。方法:49例患者的人口统计学特征、人体测量、生化结果、食物消费记录和主观总体评估(SGA)筛查工具(25 DN-3;收集肾内科随访的DN-4患者24例。采用国际肾脏营养与代谢学会(ISRNM)的标准来测定皮尤。结果:56%的DN-3和66.7%的DN-4被诊断为糖尿病超过15年。两组在总体重、体肌重量、肌酐、微量白蛋白尿和eGFR值方面存在差异(结论:我们的研究为土耳其未接受透析的DN患者存在PEW提供了总体印象。在患有DN-3和DN-4的患者中,每日能量和常量营养素摄入量符合推荐值。根据ISRNM标准,皮尤的患病率随着疾病分期的进展而增加。在评估营养不良方面,PEW被观察到比SGA更有效。
{"title":"Determination of nutritional status and protein-energy wasting in patients with diabetic nephropathy.","authors":"Elif Karakas, Hatice Colak, Fatma Esra Gunes, Berna Karakoyun","doi":"10.14744/nci.2023.66503","DOIUrl":"10.14744/nci.2023.66503","url":null,"abstract":"<p><strong>Objective: </strong>This study aims to evaluate the nutritional status of patients with stage 3 and 4 diabetic nephropathy (DN; DN-3 and DN-4) and to explain the effect of DN stages on the prognosis of protein-energy wasting (PEW).</p><p><strong>Methods: </strong>Data from demographic characteristics, anthropometric measurements, biochemical findings, food consumption records, and the Subjective Global Assessment (SGA) screening tool of 49 patients (25 DN-3; 24 DN-4) who were followed at the nephrology department were collected. The criteria of the International Society of Renal Nutrition and Metabolism (ISRNM) were used to determine PEW.</p><p><strong>Results: </strong>56% of DN-3 and 66.7% of DN-4 have been diagnosed with diabetes for over 15 years. The groups differed in total body weight, body-muscle weight, creatinine, microalbuminuria, and eGFR values (p<0.05). Protein (g/kg) intake was only different between the groups (p<0.05). 18.4% of patients had SGA-B score, and 26.5% had PEW.</p><p><strong>Conclusion: </strong>Our study provides a general impression about the presence of PEW in DN patients not receiving dialysis in Turkiye. In patients with DN-3 and DN-4, daily energy and macronutrient intakes are adequate by recommendation. According to ISRNM criteria, the prevalence of PEW increased with advancing disease stage. PEW was observed to be more effective than SGA in assessing malnutrition.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"11 6","pages":"560-568"},"PeriodicalIF":0.0,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11622758/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142804047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Northern clinics of Istanbul
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1